FDA’s ODAC rules unanimously on a faster way to approve multiple myeloma therapies
MIAMI, FLORIDA (April 12, 2024) – An advisory committee at the U.S. Food and Drug Administration voted 12-0 today in...
Utah Governor’s Medal given to Neli Ulrich, Ph.D., MS, for Outstanding Research and Leadership
Neli Ulrich, PhD, MS, chief scientific officer and executive director of the Comprehensive Cancer Center atHuntsman Cancer Institute at the University of...
NCCN Foundation announces recipients for 2024 Young Investigator Awards honoring future leaders of cancer research
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® today announced five winners for the...
Researchers discover cell ‘crosstalk’ that triggers cancer cachexia
New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia,...
Softer tumours fuel more aggressive spread of triple-negative breast cancer
A metabolic ‘survival switch’ controlled by the stiffness of triple-negative breast tumours can significantly influence how successfully their cancerous cells...
PET/MRI accurately classifies prostate cancer patients, offers potential to avoid unnecessary biopsies
Reston, VA—PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published...
The Society of Gynecologic Oncology (SGO) and The GOG Foundation, Inc. (GOG-F) launch BRIDGES 2.0 Research Initiative with support from the Foundation for Women’s Cancer (FWC).
PRESS RELEASECredit: SGO & The GOG Foundation, Inc. PRESS RELEASE Chicago, IL and Philadelphia, PA, USA, April 11, 2024: The...
Exploring the role of artificial intelligence in early cancer detection
Two new Review articles in the peer-reviewed journal AI in Precision Oncology explore the role of artificial intelligence (AI) in...
Insilico Medicine develops novel PTPN2/N1 inhibitor for cancer immunotherapy using generative AI
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But while immunotherapy...
Duke-NUS scientists uncover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers
Scientists at Duke-NUS Medical School have uncovered why some pancreatic and colorectal cancers fail to respond to Wnt inhibitors, a...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!